Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
935 INR | +0.16% | -0.27% | +35.58% |
Apr. 24 | Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection | MT |
Apr. 23 | China Medical System's Anti-Anaemia NDA Accepted in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.58% | 11.27B | |
+19.95% | 42.78B | |
+18.59% | 22.25B | |
+13.93% | 14.39B | |
+11.88% | 13.55B | |
-9.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 5.01B | |
-8.24% | 4.51B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Launches Generic Bone Marrow Disorder Drug in US